跳至主要内容
临床试验/CTRI/2016/06/006985
CTRI/2016/06/006985已完成未知

An observational clinical trial with case control cross sectional study design to test the sensitivity of a proprietary polymeric-antibody system designed to capture and concentrate circulating tumor cells (CTCs) in blood samples of patients with certain carcinomas. - SENCTC

Actorius Innovations and Research Pvt Ltd0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Written informed consent.
  • 2. Confirmed diagnosis of stage 2-4 breast, lung, colorectal cervix uteri, prostate, stomach and head & neck cancer, (OR) no prior history of cancer.
  • 3. Stage 2-4 treatment naive, metastatic, secondary, and recurrent cancer patients.
  • 4. Able to undergo blood collection prior to initiation of chemotherapy treatment, (OR) able to provide blood sample if subject is a non-cancer control subject.

排除标准

  • 1. Patients unable to understand the research protocol and/or provide informed consent.
  • 2. Patients with known immunodeficiency, or pregnancy.

研究者

发起方
Actorius Innovations and Research Pvt Ltd

相似试验

To study sensitivity of a blood test to detect... | 临床试验